By Sylvia Hui

The fossil of a 170 million-year-old pterosaur, described as the world’s best-preserved skeleton of the prehistoric winged reptile, has been found on the Isle of Skye in Scotland, scientists said Tuesday.

The National Museum of Scotland said the fossil of the pterosaur, more popularly known as pterodactyls, is the largest of its kind ever discovered from the Jurassic period. The reptile had an estimated wingspan of more than 2.5 meters (8.2 feet), similar to that of an albatross, the museum said.

The fossil was discovered in 2017 by PhD student Amelia Penny during a field trip on the Isle of Skye in remote northwestern Scotland, when she spotted the pterosaur’s jaw protruding from rocks. It will now be added to the museum’s collection.

“Pterosaurs preserved in such quality are exceedingly rare and are usually reserved to select rock formations in Brazil and China. And yet, an enormous superbly preserved pterosaur emerged from a tidal platform in Scotland,” said Natalia Jagielska, a doctoral student at the University of Edinburgh who is the author of a new scientific paper describing the find.

Steve Brusatte, a professor of palaeontology at Edinburgh University, said the discovery was the best one found in Britain since the early 1800s, when celebrated fossil hunter Mary Anning uncovered many significant Jurassic fossils on the southern English coast.

He said the fossil had “feather light” bones, “as thin as sheets of paper,” and it took several days to cut it from rock using diamond-tipped saws as his team battled against encroaching tides.

It “tells us that pterosaurs got larger much earlier than we thought, long before the Cretaceous period when they were competing with birds, and that’s hugely significant,” Brusatte added.

The pterosaur has been given the Gaelic name Dearc sgiathanach, which translates as “winged reptile."

Pterosaurs were the first vertebrates to fly, some 50 million years before birds. They lived as far back as the Triassic period, about 230 million years ago. They were previously thought to have been much smaller during the Jurassic period.

Share:
More In Science
FDA Panel Recommends Pfizer Vaccine for Kids Ages 5-11
An FDA panel has recommended the low-dose Pfizer vaccine for kids ages five to 11. The recommendation now cues up the FDA to authorize the vaccine. Next week, the CDC will consider its own authorization. Once signed off by the CDC, the Pfizer vaccine can be administered in children immediately. Dr. Christina Johns, Senior Medical Advisor at PM Pediatrics, joined Cheddar's Search for a Cure.
A Look Ahead at G20 Summit and COP26 on Addressing the Climate Crisis
World leaders will converge this weekend at the 2021 G20 Summit in Rome and the UN COP26 conference in Glasgow with the climate crisis on the agenda. Lord Adair Turner, chair of the Energy Transitions Commission, joined Cheddar to discuss what people can expect to come out of the climate-focused conferences. Turner also noted that one of the biggest hurdles for the attending nations will be coming to a uniform decision on expanding on the Paris Climate Accord goals that have become insufficient to prevent global warming by 1.5 degrees celsius.
Expanding Genetic Testing for Women Everywhere
Nicole Lambert, President at Myriad Genetics joins ChedHER to discuss how to expand access to genetic testing for all women, and how her experience as a 'pre-vivor' motivates her role in the industry.
Proptech Startup Juno Raises $20 Million
Proptech startup Juno recently raised $20 million in a Series A funding round. The company says the funds will be used to further its mission of building sustainable and affordable apartment buildings across the United States. Juno Co-Founder and CEO Jonathan Sherr joined Cheddar News' Closing Bell to discuss.
Innovation in Breast Cancer Screening
Stacey Stevens, President of iCAD, joins 'Cheddar Innovates' to discuss how 'Profound A.I. Risk' works as a short-term breast cancer risk estimation for women.
Merck to Offer Poorer Countries COVID-19 Pill Formula for Free
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Deal or No Deal, ISIS Threat & Memecoin Insanity
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
Load More